US Stock MarketDetailed Quotes

STOK Stoke Therapeutics

Watchlist
  • 12.110
  • +0.200+1.68%
Close Nov 29 13:00 ET
  • 12.110
  • 0.0000.00%
Post 17:01 ET
641.43MMarket Cap-5822P/E (TTM)

Stoke Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Stoke Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 2.267M --
-- 2024/Q4 -- / 4.100M --
-- 2024/Q3 4.894M / 3.600M --
-- 2024/Q2 4.831M / 3.256M --
-- 2024/Q1 4.216M / 3.214M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.267M--
--2024/Q4-- / 4.100M--
--2024/Q34.894M / 3.600M--
--2024/Q24.831M / 3.256M--
--2024/Q14.216M / 3.214M--

Unlock Free Earnings Estimates

Stoke Therapeutics Earnings Reports

  • Stoke Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 05:06

  • Stoke Therapeutics | 8-K: Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates

    Nov 5 20:06

  • Stoke Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 04:10

  • Stoke Therapeutics | 8-K: Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates

    Aug 7 19:06

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data